Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Benjamin

Showing results (371-380 of 462) with videos related to

Pageof 47
Sort By:
Early Human Development|July 9, 2016
Safety of histamine-2 receptor blockers in hospitalized VLBW infantsAndrew Romaine, Daniel Ye, Zachary Ao, et al.
The American Journal of Medicine|March 11, 2009
Staphylococcus aureus bacteremia among patients with health care-associated feverMartin E Stryjewski, Zeina A Kanafani, Vivian H Chu, et al.
Antimicrobial Agents and Chemotherapy|September 24, 2008
Population pharmacokinetics of fluconazole in young infantsK C Wade, D Wu, D A Kaufman, et al.
Eukaryotic Cell|July 13, 2006
Calcineurin controls growth, morphology, and pathogenicity in Aspergillus fumigatusWilliam J Steinbach, Robert A Cramer, B Zachary Perfect, et al.
Antimicrobial Agents and Chemotherapy|November 30, 2011
Anidulafungin for neonatal hematogenous Candida meningoencephalitis: identification of candidate regimens for humans using a translational pharmacological approachPeter A Warn, Joanne Livermore, Susan Howard, et al.
The Journal of Antimicrobial Chemotherapy|September 25, 2018
Effect of fluconazole prophylaxis on Candida fluconazole susceptibility in premature infantsJulie Autmizguine, P Brian Smith, Kristi Prather, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|March 14, 2026
Evaluating the duration of post-discontinuation therapeutic ampicillin exposures in preterm infantsAngelique E Boutzoukas, Jennifer Le, Ryan Kilpatrick, et al.
Therapeutic Drug Monitoring|December 23, 2017
Comparative Analysis of Ampicillin Plasma and Dried Blood Spot Pharmacokinetics in NeonatesJennifer Le, Brenda Poindexter, Janice E Sullivan, et al.
The Pediatric Infectious Disease Journal|March 10, 2020
Hospital-acquired Pneumonia and Ventilator-associated Pneumonia in Children: A Prospective Natural History and Case-Control StudyJessica E Ericson, John McGuire, Marian G Michaels, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|February 12, 2026
External Pharmacokinetic Model Evaluation of Caffeine in Critically Ill Neonates With Heart Disease Using Data Collected From a Pragmatic Platform TrialCourtney Hallock, Annalisa Hawk, Calla Castro, et al.
Pageof 47

Showing results (371-380 of 462) with videos related to

Sort By:
Pageof 47
Early Human Development|July 9, 2016
Safety of histamine-2 receptor blockers in hospitalized VLBW infantsAndrew Romaine, Daniel Ye, Zachary Ao, et al.
The American Journal of Medicine|March 11, 2009
Staphylococcus aureus bacteremia among patients with health care-associated feverMartin E Stryjewski, Zeina A Kanafani, Vivian H Chu, et al.
Antimicrobial Agents and Chemotherapy|September 24, 2008
Population pharmacokinetics of fluconazole in young infantsK C Wade, D Wu, D A Kaufman, et al.
Eukaryotic Cell|July 13, 2006
Calcineurin controls growth, morphology, and pathogenicity in Aspergillus fumigatusWilliam J Steinbach, Robert A Cramer, B Zachary Perfect, et al.
Antimicrobial Agents and Chemotherapy|November 30, 2011
Anidulafungin for neonatal hematogenous Candida meningoencephalitis: identification of candidate regimens for humans using a translational pharmacological approachPeter A Warn, Joanne Livermore, Susan Howard, et al.
The Journal of Antimicrobial Chemotherapy|September 25, 2018
Effect of fluconazole prophylaxis on Candida fluconazole susceptibility in premature infantsJulie Autmizguine, P Brian Smith, Kristi Prather, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|March 14, 2026
Evaluating the duration of post-discontinuation therapeutic ampicillin exposures in preterm infantsAngelique E Boutzoukas, Jennifer Le, Ryan Kilpatrick, et al.
Therapeutic Drug Monitoring|December 23, 2017
Comparative Analysis of Ampicillin Plasma and Dried Blood Spot Pharmacokinetics in NeonatesJennifer Le, Brenda Poindexter, Janice E Sullivan, et al.
The Pediatric Infectious Disease Journal|March 10, 2020
Hospital-acquired Pneumonia and Ventilator-associated Pneumonia in Children: A Prospective Natural History and Case-Control StudyJessica E Ericson, John McGuire, Marian G Michaels, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|February 12, 2026
External Pharmacokinetic Model Evaluation of Caffeine in Critically Ill Neonates With Heart Disease Using Data Collected From a Pragmatic Platform TrialCourtney Hallock, Annalisa Hawk, Calla Castro, et al.
Pageof 47